Latest Breaking News On - Ono pharmaceutical - Page 3 : comparemela.com

Turbine Receives Investment from Accenture

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesSzabolcs nagyMerck co incUnited states global health innovation fundCancer research horizonsSimulated cellOno pharmaceuticalGlobal health innovation fundMassmutual ventures

Accenture Invests in Turbine to Accelerate Use of AI-Powered Cell Simulations for Biopharma Research and Development

Accenture Invests in Turbine to Accelerate Use of AI-Powered Cell Simulations for Biopharma Research and Development
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesPetra jantzerTom lounibosSzabolcs nagyUnited states global health innovation fundCancer research horizonsMerck co incAccenture life sciencesAccenture venturesBusiness wireSimulated cellSimulated cellsAccenture venture project spotlightProject spotlightOno pharmaceuticalGlobal health innovation fund

Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial

Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaBristol myers squibbJoseph fioreCompany opdivoOno pharmaceutical coEuropean unionDrug administrationExchange commissionBristol myersMyers squibbBetter futureFatal immune mediated adverseFull prescribing informationAllogeneic hematopoietic stem cellMultiple myeloma

Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights

Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMarie campinellDaniel passeriJonathan pappasDrug administrationCorporate communicationsAmerican society of clinical oncologyLifesci communicationsCue biopharma incBiopharma reports first quarterRecent businessClinical oncologyAnnual meetingOno pharmaceuticalOption agreementConsolidated statements

European Medicines Agency Validates Bristol Myers Squibb s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite

Application based on results from the CheckMate -8HW study, in which Opdivo plus Yervoy demonstrated statistically significant and clinically meaningful improvement in progression-free survival.

United statesSouth koreaYervoy opdivoBristol myers squibbDana walkerAmerican society of clinical oncologyCompany opdivoExchange commissionDrug administrationOno pharmaceutical coEuropean unionEuropean medicines agencyPlus yervoyFirst line treatmentAdult patientsMicrosatellite instability